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Mechanisms by which the hypothalamus senses nutritional status are important for many metabolic
diseases, including obesity and diabetes. Now, Coppola et al. (2007) report that hypothalamic neu-
rons sense nutritional deficit through a cascade of events involving leptin, corticosterone, and glial
production of thyroid hormone, leading to neuronal induction of uncoupling protein.It all seemed so simple. A decrease in
the levels of the fat-produced hormone
leptin signals the hypothalamus that fat
levels have fallen, and hypothalamic
neurons activate a complex program,
including hunger, to preserve energy
and restore fat levels (Ahima et al.,
1996). Impairments in this mechanism,
including deficiency in or insensitivity
to leptin, would, by misleading the
brain into underestimating available
nutritional resources, then plausibly
constitute a major cause of obesity
and diabetes. If only. A series of stud-
ies, including those reported in this
issue of Cell Metabolism by Coppola
et al. (2007), have now elegantly
demonstrated that hypothalamic re-
sponses to food deprivation involve at
least three hormones, two cell types,
and an unexpected interlocutor, un-
coupling protein 2 (UCP2).
Even before the studies leading to
this paper, it was clear that responses
to fasting involved more hormones
than leptin since, for example, elevated
corticosterone mediates the induction
of hypothalamic agouti-related pep-
tide (AgRP) and neuropeptide Y (NPY)
during fasting and diabetes (Makimura
et al., 2003). Since many of the neuro-
endocrine responses to food depri-
vation, including elevation of plasma
corticosterone, are reversed by elevat-
ing plasma leptin levels (Ahima et al.,
1996), these observations suggest
that at least some of the effects of lep-
tin deficiency are mediated indirectly
via leptin’s regulation of glucocorticoid
secretion. Coppola et al. (2007) now
make a strong case that effects of cor-
ticosterone on at least some neuroen-
docrine responses to fasting are alsoindirect and are mediated by yet an-
other hormone, the thyroid hormone
T3, produced by a surprising source,
a specialized class of hypothalamic
glia called tanycytes. In previous stud-
ies, the authors had demonstrated that
tanycytes express the enzyme type 2
deiodinase (Diano et al., 2003a), which
locally converts a precursor to the
active T3. The authors further dem-
onstrated that the induction of type 2
deiodinase by fasting (as with AgRP
and NPY [Makimura et al., 2003]) is
mediated by fasting-induced elevation
of glucocorticoid secretion (Coppola
et al., 2005).
In the present study, Coppola et al.
(2007) demonstrate the physiological
significance of the induction of hypo-
thalamic type 2 deiodinase by fasting.
First, the authors showed that the ta-
nycytes expressing type 2 deiodinase
directly contact hypothalamic neurons
expressing AgRP and NPY (the same
neurons express both genes). As they
had reported previously, fasting in-
creased the expression of type 2 deio-
dinase and the local hypothalamic pro-
duction of T3. In the periphery, T3 is
known to induce the activity of uncou-
pling proteins (Collin et al., 2005); such
proteins ‘‘uncouple’’ the transfer of
protons down the mitochondrial pro-
ton gradient from the production of
ATP, which, by reducing the efficiency
of ATP production, produces heat,
a mechanism accounting for the ther-
mogenic (and antiobesity) effects of
peripheral T3. The authors therefore
examined whether the fasting-induced
increase in hypothalamic T3 produc-
tion was associated with an induction
of hypothalamic UCP2, and they ob-Cell Metabolisserved that this was indeed the case.
It is also known that the expression of
uncoupling protein in the periphery is
associated with increased numbers
of mitochondria, and the authors also
observed that this was the case in hy-
pothalamic neurons expressing NPY
and AgRP. Finally, and most impor-
tantly, the authors demonstrated that
blocking the production of T3 blocked
the induction of fasting-induced UCP2
and that ablation of UCP2 diminished
the activating effects of fasting on
NPY/AgRP neurons. These observa-
tions led to the conclusion that fasting
reduces plasma leptin, which through
hypothalamic action leads to the ele-
vation of peripheral corticosterone,
which then acts on hypothalamic tany-
cytes to increase local production of
T3, which then stimulates UCP2 in
NPY/AgRP neurons, leading to an
increase in number of mitochondria
and activity of these neurons (Figure 1).
Why bother with such a Rube Gold-
bergmechanism?One interestingpos-
sibility is that fasting-induced hypo-
thalamic UCP2 mediates the robust
energy-conserving drop in core body
temperature that occurs during fasting
(Conti et al., 2006). The authors also
speculate that one function of the
mechanism is, by increasing mito-
chondrial number, to increase the bio-
energetic capacity of the NPY/AgRP
neurons that are chronically activated
by fasting. This hypothesis is sup-
ported by the observation that UCP2
transgenic mice exhibit elevated ATP
levels in the hippocampus (Diano
et al., 2003b). On the other hand,
such a mechanism would be some-
what paradoxical in that the increasedm 5, January 2007 ª2007 Elsevier Inc. 1
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Food deprivation reduces the production of leptin by fat. This removes the inhibitory effect of leptin
on corticosterone secretion by the adrenal gland (through amechanism still unresolved), leading to
increased corticosterone secretion. The increased corticosterone stimulates the production of
type 2 deiodinase in hypothalamic tanycytes, leading to increased local production of T3. T3
diffuses to nearby NPY/AgRP neurons (adjacent, but shown spatially separate here for clarity),
where it stimulates UCP2 production. Abrogation of any of these steps attenuates several neuro-
endocrine responses to fasting.mitochondrial number appears to be
secondary to induction ofUCP2,which
actually reduces mitochondrial effi-
ciency. For example, overexpression
of UCP2 in pancreatic b cells reduces
ATP synthesis and sensitivity to glu-
cose, whereas ablation of UCP2 in
pancreatic b cells increases ATP syn-
thesis andsensitivity to glucose (Zhang
et al., 2001). It is not clear why elevated
UCP2 expression should produce the
same energetic effect in NPY/AgRP
neurons as ablating UCP2 expression
produces inpancreaticbcells. Further-
more, since NPY/AgRP neurons are
inhibited by both leptin and glucose
(Mountjoy et al., 2006), and since inhi-
bition of neuronal activity is mediated
through glucose metabolism (Yang
et al., 2004), an increase in metabolic
capacity during fasting would increase
the sensitivity of these neurons to glu-
cose and thus, if anything, would be
expected to silence, rather than acti-
vate, these neurons.
It is perhaps more plausible that
UCP2 produces the same effect in
NPY/AgRP neurons as it does in pan-
creatic b cells, viz., reduction of meta-
bolic efficiency and, thus, sensitivity2 Cell Metabolism 5, January 2007 ª200to glucose (Zhang et al., 2001). In fact,
reducing metabolic efficiency by re-
ducing the inhibitory effect of glucose
activates these glucose-inhibited neu-
rons. Such a mechanism could opti-
mize the integration of the signal for
long-term energy availability, leptin,
with the signal for short-term energy
availability, glucose. It should be
noted, however, that reducing neuro-
endocrine sensitivity to glucose is
not necessarily inconsistent with in-
creased metabolic capacity. A key re-
sult of decreasing metabolic capacity
is an increase in the number of NADH
molecules required to produce one
ATP molecule, which would be ex-
pected to reduce the ratio of cytoplas-
mic NADH to ATP molecules. Several
lines of evidence suggest that molecu-
lar effects of glucosemay bemediated
through NADH rather than ATP (Yang
et al., 2004), soUCP2expression could
reduce glucose sensitivity of NPY/
AgRP neurons while still maintaining
ATP production. Since cytoplasmic
NADH is also produced by lactate
metabolism, this mechanism also sug-
gests that hypothalamic glial cells,
which are well placed to monitor blood7 Elsevier Inc.glucose and supply lactate to NPY/
AGPR neurons to support elevated
neuronal activity (Magistretti et al.,
1999), are particularly suitable to coor-
dinate these metabolic signals. Thus,
the studies by Coppola et al. (2007)
raise many fascinating questions for
future analysis.
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